Sign in

CIK 0001516551

  • Non-accelerated filer
  • Smaller reporting company

Skye Bioscience, Inc.

Sign in to watch
Ticker
SKYE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
450692882
Phone
+1 858-410-0266
Business address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
Former names
Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$613,506
in 6 filings

Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-01-18 Murphy Brian Stuart CEO, Chief Medical Officer Grant or award +900,000 1,275,000
2018-01-18 LYKOS COSMAS N Chairman Grant or award +900,000 4,599,400
2018-01-18 Berecz Elizabeth Chief Financial Officer Grant or award +700,000 1,050,000
2017-03-13 Lapham Reg Alexander 10% owner Option exercise −119,700 $1.00 $120K 3,787,500
2015-10-20 INGRAM DOUGLAS S Vice Chairman Grant or award +60,000 372,500
2015-10-20 McLaughlin Gerald W. Director Grant or award +30,000 61,250
2015-10-20 GEORGE THOMAS Director Grant or award +60,000 60,000
2015-10-20 LYKOS COSMAS N Chairman Grant or award +325,000 3,699,400
2015-10-20 Berecz Elizabeth Chief Financial Officer Grant or award +350,000 350,000
2015-10-20 Murphy Brian Stuart CEO, Chief Medical Officer Grant or award +375,000 375,000
2015-08-20 INGRAM DOUGLAS S Vice Chairman Conversion +312,500 312,500
2015-08-20 INGRAM DOUGLAS S Vice Chairman Conversion · Series A Preferred Stock −100,000 0
2015-08-20 McLaughlin Gerald W. Director Conversion +31,250 31,250
2015-08-20 McLaughlin Gerald W. Director Conversion · Series A Preferred Stock −10,000 0
2015-06-01 INGRAM DOUGLAS S Vice Chairman Grant or award · Stock Option (Right to Buy) +40,000 40,000
2015-05-29 McLaughlin Gerald W. Director Purchase · Series A Preferred Stock +10,000 $2.50 $25K 10,000
2015-05-29 McLaughlin Gerald W. Director Purchase · Common Stock Warrant (Right to Buy) +2,000 2,000
2015-04-10 Ladin Brian D 10% owner Sale −11,830 $4.93 $58K 249,098
2015-04-08 Ladin Brian D 10% owner Sale −23,000 $4.69 $108K 276,728
2015-04-08 Ladin Brian D 10% owner Sale −15,800 $4.79 $76K 260,928

Page 14 of 15 · 292 trades